Glaxo offers NHS rebate if latest cancer drug fails to outperform Pfizer rival

, Comments 0 comments

GlaxoSmithKline has agreed a new deal with the NHS that will see the pharmaceuticals giant hand back money to the Government should one of its drugs fail to outperform a rival medicine.

0 Comments To This Article